These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22186244)

  • 1. The elevated expression of osteopontin and vascular endothelial growth factor in sinonasal inverted papilloma and its relationship with clinical severity.
    Liu W; Li Z; Luo Q; Lai Y; Zhang J; Chen F; Shi J; Li H; Xiong G; Xu G; Wang H
    Am J Rhinol Allergy; 2011; 25(5):313-7. PubMed ID: 22186244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive correlation of osteopontin, cyclooxygenase-2 and vascular endothelial growth factor in gastric cancer.
    Tang H; Wang J; Bai F; Zhai H; Gao J; Hong L; Xie H; Zhang F; Lan M; Yao W; Liu J; Wu K; Fan D
    Cancer Invest; 2008 Feb; 26(1):60-7. PubMed ID: 18181047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypoxic synovial environment regulates expression of vascular endothelial growth factor and osteopontin in juvenile idiopathic arthritis.
    Bosco MC; Delfino S; Ferlito F; Puppo M; Gregorio A; Gambini C; Gattorno M; Martini A; Varesio L
    J Rheumatol; 2009 Jun; 36(6):1318-29. PubMed ID: 19369471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentiviral-mediated siRNA targeted against osteopontin suppresses the growth and metastasis of gastric cancer cells.
    Wang ZM; Cui YH; Li W; Chen SY; Liu TS
    Oncol Rep; 2011 Apr; 25(4):997-1003. PubMed ID: 21286666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of osteopontin promotes the radiosensitivity of breast cancer cells by reducing the expression of hypoxia inducible factor 1 and vascular endothelial growth factor.
    Yang L; Zhao W; Zuo WS; Wei L; Song XR; Wang XW; Zheng G; Zheng MZ
    Chin Med J (Engl); 2012 Jan; 125(2):293-9. PubMed ID: 22340562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of osteopontin expression in human gastric carcinoma.
    Higashiyama M; Ito T; Tanaka E; Shimada Y
    Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin is involved in the formation of malignant pleural effusion in lung cancer.
    Cui R; Takahashi F; Ohashi R; Yoshioka M; Gu T; Tajima K; Unnoura T; Iwakami S; Hirama M; Ishiwata T; Iwase A; Takahashi K
    Lung Cancer; 2009 Mar; 63(3):368-74. PubMed ID: 18752867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
    Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and significance of osteopontin and muscle segment homeobox gene Msx2 in sinonasal inverted papilloma].
    Wu Y; Cui S; Wu Q; Ma Z; Yuan W
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Oct; 27(20):1114-7. PubMed ID: 24479353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protein and mRNA expression of osteopontin in lung cancer and clinical significance thereof].
    Gui SY; Li HH; Zuo L; Zhou Q; Wu Q; Wang Y
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(45):3219-23. PubMed ID: 18399118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
    Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of expression of cell cycle-related proteins in malignant transformation of sinonasal inverted papilloma.
    Kim SG; Lee OY; Choi JW; Park YH; Kim YM; Yeo MK; Kim JM; Rha KS
    Am J Rhinol Allergy; 2011; 25(2):75-81. PubMed ID: 21679505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Over-expression of osteopontin in non-small cell lung cancers: its clinical significance].
    Hu Z; Xiao T; Lin DM; Guo SP; Zhang ZQ; Di XB; Cheng SJ; Gao YN
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):591-5. PubMed ID: 18210878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin induced vascular endothelial growth factor production in dispersed nasal polyp cells through the phosphatidylinositol 3-kinase-protein kinase B and the extracellular signal-regulated kinase 1/2 pathways.
    Du J; Mao H; Ouyang H; Xin Y
    Am J Rhinol Allergy; 2017 Jul; 31(4):35-41. PubMed ID: 28716167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance and expression of VEGF and its receptor in nasal inverted papillomas and the correlation with malignant phenotype].
    Kong H; Guan Q; Sun X; Wang N
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 26(8):337-8, 342. PubMed ID: 22730813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of DLEC1 in sinonasal inverted papilloma and squamous cell carcinoma.
    Chang PH; Huang CC; Lee TJ; Lee YS; Tsai CN
    J Otolaryngol Head Neck Surg; 2012 Apr; 41(2):94-101. PubMed ID: 22569009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of osteopontin in chronic rhinosinusitis with and without nasal polyps.
    Lu X; Zhang XH; Wang H; Long XB; You XJ; Gao QX; Cui YH; Liu Z
    Allergy; 2009 Jan; 64(1):104-11. PubMed ID: 19076536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumors.
    Sulzbacher I; Birner P; Trieb K; Lang S; Chott A
    Virchows Arch; 2002 Oct; 441(4):345-9. PubMed ID: 12404059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression.
    Castellano G; Malaponte G; Mazzarino MC; Figini M; Marchese F; Gangemi P; Travali S; Stivala F; Canevari S; Libra M
    Clin Cancer Res; 2008 Nov; 14(22):7470-80. PubMed ID: 19010864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.